Abstract
Reports on positron emission tomography have become more common in the oncology literature. After a short introduction to positron emission tomography, this review will look at the data relating to the use of this technology in the diagnosis, the staging, and the post-treatment evaluation of patients with lung cancer and will discuss its potential role in these evaluations.
MeSH terms
-
Carcinoma, Bronchogenic / diagnostic imaging
-
Carcinoma, Bronchogenic / pathology
-
Carcinoma, Bronchogenic / secondary
-
Carcinoma, Bronchogenic / therapy
-
False Negative Reactions
-
Fluorodeoxyglucose F18
-
Humans
-
Lung / abnormalities
-
Lung / diagnostic imaging
-
Lung Neoplasms / diagnostic imaging*
-
Lung Neoplasms / pathology
-
Lung Neoplasms / therapy
-
Lymphatic Metastasis / diagnostic imaging
-
Neoplasm Recurrence, Local / diagnostic imaging
-
Neoplasm Staging
-
Radiopharmaceuticals
-
Tomography, Emission-Computed*
-
Treatment Outcome
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18